Gadoversetamide
C20H34GdN5O10
661.76
(Gadoversetamide) [8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)], gadolinium.
[N,N-Bis[2-[(carboxymethyl)[[(2-methoxyethyl)car bamoyl]methyl]amino]ethyl]glycinato(3-)]gadolinium [131069-91-5]
(Gadoversetamide) [8,11-bis(carboxymethyl)-14-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)], gadolinium.
[N,N-Bis[2-[(carboxymethyl)[[(2-methoxyethyl)car bamoyl]methyl]amino]ethyl]glycinato(3-)]gadolinium [131069-91-5]
» Gadoversetamide contains not less than 97.0 percent and not more than 102.0 percent of C20H34GdN5O10, calculated on an anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Gadodiamide Related Compound B RSUSP Gadoversetamide RS
USP Gadoversetamide Related Compound A RS